Greenfern Industries Limited Ordinary Shares Company Details Registered Office: 127 Normanby Road, Normanby 4671 Postal Address: 127 Normanby Road, Normanby 4671 Telephone: +64-27-420-2476 Facsimile
By Paul McBeth Nov. 20 (BusinessDesk) - Bethunes Investments shareholders will vote next month on a deal to use its NZX listing as a vehicle for freight and logistics firm Transport Investments Ltd to
A boom in Pacific Edge’s Cxbladder test sales boosted the firm’s operating revenue soar by 71%, with a helping hand from favourable exchange rates. Chief executive Peter Meintjes said the 2023 fin
Pacific Edge has halved its sales team after uncertainty over its future in its core US market, with a pending decision on whether medicare contractor Novitas will cover US testing. The cancer diag
Investors have given Pacific Edge a ringing endorsement, bidding more than $80 million into a share placement originally intended to raise just $60m. The cancer diagnostic firm increased the size of t
Shares of Pacific Edge plunged 89.9% on news that Medicare coverage of Cxbladder tests in the US is expected to cease from July 17. The shares resumed trading at 5 cents, having been halted on Tuesday
Pacific Edge has pushed back against its United States Medicare administrator saying there are “substantial misunderstandings” regarding the use of its tests, as it fights to hold on to its bigges
Sheldon has launched an unsolicited offer for any remaining SeaDragon shares at 4 cents a share. Sheldon is owned by a consortium that up until recently were the major shareholders in SeaDragon, inc
Pacific Edge is still working through the implications of the Medicare contractor decision that its suite of products do not meet the threshold for coverage under the US Social Security Act. Trading
Pacific Edge’s shares jumped as much as 6.3% as investors wait for the cancer diagnostic company to reveal whether major US health insurance provider will keep using its bladder tests. The S&P/NZX 5
Cancer diagnostics business Pacific Edge will apply for a secondary listing on the Australian stock exchange and expects its shares to begin trading on ASX in September. The firm’s board said being
By Suze Metherell Aug. 27 (BusinessDesk) - New Zealand shares rose to a record as Pacific Edge won a contract with US healthcare provider Kaiser Permanente and Genesis Energy posted earnings that b
Marlin Global Limited 20/05/2022 $1.28 Warrants
Pacific Edge has long wanted to crack the United States market, which it has seen for a long time as validating the hundreds of millions spent in developing its Cxbladder non-invasive cancer detection
New Zealand Rugby is poised for its biggest structural change in 25 years of professionalism with the bulk of its income and expenses carved out into a subsidiary if the controversial Silver Lake deal
A judgment is expected to be delivered on Thursday. The S&P/NZX 50 index declined 122.94 points or 1.03% to 11,759.15....
The Asia Pacific Trust ("the Fund") is a unit trust, as defined in the Units Trust Act 1960.The beneficial interest in the Fund is divided into units, with each unit representing an equal interest in.
A judgment is expected to be delivered on Thursday. The S&P/NZX 50 index declined 122.94 points or 1.03% to 11,759.15....
Pacific Edge Limited is a cancer diagnostic company specialising in the discovery and commercialisation of diagnostic and prognostic tests for the better detection and management of cancer. The compan
By Paul McBeth Oct. 27 (BusinessDesk) - New Plymouth-based freight and logistics group Transport Investments Ltd plans to join the NZX through a backdoor listing via Bethunes Investment in a deal valu
2 Cheap Cars Group Limited Ordinary Shares
Manawa Energy Limited Ordinary Shares Company Details Registered Office: 108 Durham Street, Tauranga 3110 Postal Address: 108 Durham Street, Tauranga 3110 Telephone: +64-27-582-6600 Facsimile: n/a Web
New Zealand's main share index rose on Wednesday after Pacific Edge announced a US healthcare provider would now be able to order its cancer test more quickly and easily. The S&P/NZX 50 Index rose 64.
Third party data: All data displayed on the FundSource pages (Data) on BusinessDesk has been sourced from an independent third party, FE Fundinfo. NZME and its related bodies corporate and affiliates (together NZME) do not make any representation as to the currency, fairness, accuracy, completeness or reliability of the Data. Nor will NZME have any liability to any person in relation to the use of or reliance on the Data.
No financial or investment advice: The Data is general information only. It is not financial product or investment advice or an investment recommendation, and has not been prepared taking into account the objectives, financial situation or needs of any person. Potential investors should seek their own independent advice from a qualified financial adviser prior to making an investment decision. NZME makes no recommendation in relation to, and accept no responsibility or ongoing liability for, any person’s investment decisions.
No offer: The Data is only to be accessed by New Zealand residents from within New Zealand, and may not be copied or distributed to any other person. The Data does not constitute an offer or solicitation to offer financial products or conduct investment business in New Zealand or any other jurisdiction.
No guarantee: Past performance information should not be relied upon as (and is not) a promise, representation, warranty or guarantee as to the past, present or future performance. NZME does not guarantee repayment of any capital or payment of any returns on capital invested in the investments referred to in the Data.
Missing data? All data comes from FE fundinfo. BusinessDesk can help you get your data loaded and updated. Email [email protected] for help.